M, V. B., JM, P., P, C., L, G., M, F., M, G., . . . A, L. (2024). Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: The DEBBRAH trial.
Citação norma ChicagoM, Vaz Batista, et al. Trastuzumab Deruxtecan in Patients With Previously Treated HER2-low Advanced Breast Cancer and Active Brain Metastases: The DEBBRAH Trial. 2024.
Citação norma MLAM, Vaz Batista, et al. Trastuzumab Deruxtecan in Patients With Previously Treated HER2-low Advanced Breast Cancer and Active Brain Metastases: The DEBBRAH Trial. 2024.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.